| Professor Sam El-Osta's (second from right, back row) research group |
When it comes to the epigenome, there is a fine line between clarity and confusion—walk that line and you will discover another fascinating level of transcription control.
So begins a review of the current state-of-play of studies into epigenetics in diabetic complications led by Professor Sam El-Osta from Monash University’s Department of Diabetes. The paper, which focusses particularly on the complication diabetic nephropathy (kidney disease), appeared on the cover of last month’s edition of ‘Diabetologia’.





